Navigation Links
Festschrift Issue honoring Judah Folkman, M.D. in Lymphatic Research and Biology

New Rochelle, NY, January 6, 2009Dedicated to the memory and scientific accomplishments of Dr. Judah Folkman, who pioneered the fields of angiogenesis and vasculogenesis and shed light on the link between blood supply and neoplastic disease, the newly released special double issue (Volume 6, Number 3-4) of Lymphatic Research and Biology includes a series of papers that reflect the research impact of one of the pre-eminent physician-scientists of his generation. Lymphatic Research and Biology is a peer-reviewed journal published by Mary Ann Liebert, Inc. ( The issue is available free online at

"Not only did Judah Folkman single-handedly create the research discipline of angiogenesis, he also played a very fundamental role in the extension of the same principles to the field of lymphangiogenesis research," says Stanley G. Rockson, MD, Editor-in-Chief of the Journal and Chair of the Scientific Advisory Board of the Lymphatic Research Foundation. Dr. Rockson, who is the Chief of Consultative Cardiology, the Allan and Tina Neill Professor of Lymphatic Research and Medicine, and Director of the Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, feels that "his impact as a teacher and mentor is almost incalculable, and we are proud to present these contributions by leading scientists whose training and career path directly reflect the impact of Dr. Folkman's work and teaching."

Leah Cueni and Michael Detmar provide an in-depth review of the field in "The Lymphatic System in Health and Disease," and Carrie Shawber and Jan Kitajewski describe "Arterial Regulators Taken Up by Lymphatics." In the paper "Why and How Do Tumors Stimulate Lymphangiogenesis?," Yihai Cao explains the processes behind increased lymphatic supply to cancerous lesions. Dean Felsher explores the phenomena of oncogene addiction, cellular senescence, and the angiogenic switch in a report entitled, "Reversing Cancer From Inside and Out." In a forward-looking review, Steven Stacker and Marc Achen present "From Anti-Angiogenesis to Anti-Lymphangiogenesis: Emerging Trends in Cancer Therapy." A report by Michael Mancuso, Frank Kuhnert, and Calvin Kuo focuses on "Developmental Angiogenesis of the Central Nervous System."


Contact: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News

Related biology news :

1. A step toward tissue-engineered heart structures for children
2. Researchers create system to build transplant tissue
3. Iowa State professors genome research published in the latest issue of Science
4. Chloroplast f and m Thioredoxins Discovered in Nonphotosynthetic Tissues
5. NIH hosts event to launch Council of Science Editors global theme issue
6. 200 journals join in theme issues on poverty and human development
7. Natural product discovery by Cleveland medical researchers blocks tissue destruction
8. Knocking out cell receptor may help block fat deposits in tissues, prevent weight gain
9. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
10. Choices and Challenges forum to address nuclear power issue
11. Media highlights in the November issues of Biophysical Journal
Post Your Comments:
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces today ... its Board of Directors. --> ... recently retiring from the partnership at TPG Capital, one ... with over $140 Billion in revenue.  He founded and ... all the TPG companies, from 1997 to 2013.  In ...
(Date:11/12/2015)... Mass. , Nov. 12, 2015  Arxspan ... Institute of MIT and Harvard for use of ... discovery information management tools. The partnership will support ... both biological and chemical research information internally and ... will be used for managing the Institute,s electronic ...
(Date:11/10/2015)... , Nov. 10, 2015 ... behavioral biometrics that helps to identify and verify ... Signature is considered as the secure and accurate ... identification of a particular individual because each individual,s ... accurate results especially when dynamic signature of an ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... and HOLLISTON, Mass. , ... Inc. (Nasdaq: HART ), a biotechnology company developing ... CEO Jim McGorry will present at the ... 1, 2015 at 2:30 p.m. PT. The presentation will ... for 30 days. Management will also be available at ...
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman ... AngelList early in their initial angel funding process. Now, they are paying it ... to make early stage investments in the microbiome space. In this, they ...
Breaking Biology Technology: